[Form 4] C.H. Robinson Worldwide, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Insider sale reported by Angela K. Freeman, CHRO and ESG Officer of C.H. Robinson Worldwide (CHRW). The Form 4 discloses that on 08/11/2025 Freeman disposed of 5,713 shares of CHRW common stock in multiple transactions at a weighted average price of $116.243 per share, with sale prices ranging from $116.11 to $116.48.
After the reported sale the reporting person beneficially owns 65,728 shares, comprised of 65,459 shares issuable upon settlement of restricted stock units and deferred plan credits and 269 shares held directly. No derivative securities were reported and the Form 4 was filed by one reporting person.
Positive
- Transparent disclosure of weighted-average sale price and sale price range with offer to provide per-price details on request
- Significant retained stake: reporting person continues to beneficially own 65,728 shares, including 65,459 RSU/deferred-plan shares
Negative
- Insider disposition of 5,713 shares may be viewed negatively by some investors depending on timing and context
Insights
TL;DR: Routine officer sale of 5,713 shares; meaningful retained stake remains, resulting impact appears neutral.
The filing documents a non-derivative sale of 5,713 CHRW shares on 08/11/2025 at a weighted average price of $116.243. The disclosure includes the full sale price range and offers to provide per-price breakdowns on request, which supports transparency. Following the sale the reporting person retains 65,728 shares, largely comprised of restricted stock units and deferred plan credits, indicating continued economic exposure to the issuer.
From a market-impact perspective the transaction is a clear insider disposition but not accompanied by derivatives activity or other material corporate events in this filing, so it reads as a routine liquidity event rather than a corporate signal.
TL;DR: Filing is complete and transparent; sale is documented with weighted-average pricing and residual holdings disclosed.
The Form 4 provides required Section 16 disclosure for an officer of CHRW, including transaction code, share counts, and a weighted-average sale price with the reported price range. The explanation clarifies that 65,459 shares are issuable in settlement of restricted stock units and deferred shares, which helps investors understand the composition of the reporting person’s holdings.
There are no amendments, derivative transactions, or apparent compliance issues noted in the submission. Material governance implications are limited to standard insider reporting and the maintenance of disclosure obligations.